You are here: Industry Insights > COVID-19

News List

Merck and Ridgeback's molnupiravir, an oral COVID-19 antiviral medicine, receives first authorization in the world WorldPharmaNews
November 16, 2021
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced that the United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA)...
Primary endpoint met in COMET-TAIL Phase III trial evaluating intramuscular administration of sotrovimab for early treatment of COVID-19 WorldPharmaNews
November 16, 2021
GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Vir) (Nasdaq: VIR) announced headline data from the randomised, multi-centre, open-label COMET-TAIL Phase III trial...
EC approves Roche’s Ronapreve for Covid-19 treatment Pharmaceutical-Business-Review
November 16, 2021
The European Commission (EC) has granted marketing authorisation for Roche’s Ronapreve to treat non-hospitalised Covid-19 patients aged 12 years and above.
Israel to procure courses of Pfizer’s Covid-19 antiviral pill Pharmaceutical-Technology
November 16, 2021
The Israeli Government has entered an agreement to procure tens of thousands of courses of Pfizer’s investigational Covid-19 antiviral drug.
SSRIs Linked to Reduced Relative Risk for Mortality in COVID-19 Drugs
November 16, 2021
For patients with COVID-19, selective serotonin reuptake inhibitors (SSRIs) are associated with a reduced relative risk for mortality, according to a study published online Nov. 15 in JAMA Network Open.
COVID patients on SSRI antidepressants are less likely to die, UCSF-Stanford study finds FirstWordPharma
November 16, 2021
A large analysis of health records from 87 health care centers across the United States found that people taking a class of antidepressants called selective serotonin reuptake inhibitors (SSRIs)...
Novavax Announces Submission of Biologics License Application in South Korea for Approval of NVX-CoV2373 prnasia
November 16, 2021
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and SK bioscience, Co. Limited (SK bioscience)...
AstraZeneca to transition to ‘modest profitability’ on future COVID-19 vaccine orders CPhIonline
November 16, 2021
AstraZeneca will start to receive a modest profit from its COVID-19 vaccine as part of a post-pandemic commercial approach, the Anglo-Swedish drugmaker announced at a press conference on Friday.
Chinese mainland reports 32 locally transmitted COVID-19 cases NMPA
November 16, 2021
BEIJING -- The Chinese mainland on Sunday reported 32 new locally transmitted COVID-19 cases, the National Health Commission said in its daily report on Nov 15.
RedHill Biopharma Announces Last Patient Randomized in Part A of Ongoing Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients prnewswire
November 16, 2021
RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that the last patient has been enrolled in Part A of the Phase 2/3 study with novel...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page